Understanding how the immune system environment is controlled in high myopia cases
- 2 October 2024
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 1) , 113138
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 81 references indexed in Scilit:
- Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases (Adv. Sci. 32/2024)Advanced Science, 2024
- Analysis and validation of potential ICD-related biomarkers in development of myopia using machine learningInternational Ophthalmology, 2024
- Single‐cell RNA sequencing study of retinal immune regulators identified CD47 and CD59a expression in photoreceptors—Implications in subretinal immune regulationJournal of Neuroscience Research, 2020
- Epidemiologie und Anatomie der MyopieDer Ophthalmologe, 2019
- B lymphocytes in renal interstitial fibrosisJournal of Cell Communication and Signaling, 2017
- Liver fibrosis occurs through dysregulation of MyD88‐dependent innate B‐cell activityHepatology, 2015
- CCR2+ monocytes infiltrate atrophic lesions in age‐related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient miceEMBO Molecular Medicine, 2013
- Expression of Complement Components and Regulators by Different Subtypes of Bone Marrow-Derived MacrophagesInflammation, 2012
- Matrix Metalloproteinases and Tumor Necrosis Factor α in Glaucomatous Optic Nerve HeadArchives of Ophthalmology (1950), 2000
- Eosinophil and Neutrophil Degranulation in Ophthalmic Lesions of Wegener's GranulomatosisArchives of Ophthalmology (1950), 1991